Info message
Ce contenu n'est pas disponible en français.Scientific Highlights from Research Division Biology and Chemistry
(BIO)
Scientific Highlights
A new spin on sample delivery for membrane proteins
Proteins hover in front of the X-ray beam at a Swiss Light Source beamline. Now, spinning thin films bring on board these trickiest of proteins.
NMB/Eckelman Young Investigator Award 2022
Chiara Favaretto, PhD student in the “Radionuclide Development” group at the Center for Radiopharmaceutical Sciences, received the NMB/Eckelman Young Investigator Award for the abstract entitled: “Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging”, presented at the International Symposium on Radiopharmaceutical Sciences (iSRS 2022).
How to get chloride ions into the cell
A molecular movie shot at PSI reveals the mechanism of a light-driven chloride pump
Millions in funding for brain and quantum research
The European Research Council approves PSI projects for the development of a quantum computer and brain research worth about 5 million euros.
Terbium Triumph
Bench-to-bedside successes: Fruitful collaborations at PSI’s Center for Radiopharmaceutical Sciences make bringing Terbium-161 to the clinic a reality.
Biased signalling for better drugs
A dream drug would provide a targeted therapeutic effect without side effects. Biased signalling could make this a reality. Publishing in PNAS, PSI researchers present a platform for biased signalling-based drug discovery.
Fingerprint of Copper in Peptides Linked to Alzheimer's Disease
In an interdisciplinary project, researchers from the Laboratory of Nanoscale Biology in BIO and the Laboratory for Condensed Matter in PSD have revealed the reaction between the nitrogen atoms of the amyloid-beta peptide and copper/zinc ions by using soft X-ray absorption spectroscopy.
Effective combination cancer treatment
Combining two chemotherapeutic drugs inhibits tumour growth.
EANM Marie-Curie Award 2021 went to VIVIANE TSCHAN
Viviane Tschan received this year’s Marie-Curie Award for a new concept of radioligand therapy of prostate cancer.